pubmed-article:10098753 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:10098753 | lifeskim:mentions | umls-concept:C0014852 | lld:lifeskim |
pubmed-article:10098753 | lifeskim:mentions | umls-concept:C0286983 | lld:lifeskim |
pubmed-article:10098753 | lifeskim:mentions | umls-concept:C1705784 | lld:lifeskim |
pubmed-article:10098753 | lifeskim:mentions | umls-concept:C0024204 | lld:lifeskim |
pubmed-article:10098753 | lifeskim:mentions | umls-concept:C0007137 | lld:lifeskim |
pubmed-article:10098753 | lifeskim:mentions | umls-concept:C0027627 | lld:lifeskim |
pubmed-article:10098753 | lifeskim:mentions | umls-concept:C0033684 | lld:lifeskim |
pubmed-article:10098753 | lifeskim:mentions | umls-concept:C0812444 | lld:lifeskim |
pubmed-article:10098753 | lifeskim:mentions | umls-concept:C0017262 | lld:lifeskim |
pubmed-article:10098753 | lifeskim:mentions | umls-concept:C1413246 | lld:lifeskim |
pubmed-article:10098753 | lifeskim:mentions | umls-concept:C2911684 | lld:lifeskim |
pubmed-article:10098753 | lifeskim:mentions | umls-concept:C0185117 | lld:lifeskim |
pubmed-article:10098753 | pubmed:issue | 7-8 | lld:pubmed |
pubmed-article:10098753 | pubmed:dateCreated | 1999-4-13 | lld:pubmed |
pubmed-article:10098753 | pubmed:abstractText | Although the mechanisms of action of the transmembrane superfamilies, motility-related protein-1 (MRP-1/CD9) and KAI1/CD82, are not well known, they are reported to suppress the metastasis of several kinds of cancers. The suppression of cell motility by MRP-1/CD9 may cause suppression of the metastasis. As we could not find any reports concerning the expression of MRP-1/CD9 and KAI1/CD82 in oesophageal cancers we investigated their expression in oesophageal specimens. We conducted immunohistochemical staining for MRP1/CD9 against 108 cases of oesophageal squamous cell carcinoma using anti-MRP-1/CD9 monoclonal antibody M31-15, and for KAI1/CD82 against 104 cases using anti-KAI1/CD82 monoclonal antibody C33. To investigate the gradual expression of MRP-1/CD9 and KAI1/CD82, 24 oesophageal dysplasias were immunohistochemically stained using the same method and then investigated. The expression of both MRP-1/CD9 and KAI1/CD82 were positive on the cell membranes of normal oesophageal epithelial cells, but reduced or negative in the cancer cells. Reduced MRP-1/CD9 expressions significantly correlated to tumour depth (P = 0.0009). We found a significantly greater number of reduced or negative expression of MRP-1/CD9 and KAI1/CD82 in lymph node metastatic cases (P = 0.0003 and P= 0.0129, respectively), but not in distant metastatic cases. The 5-year survival rate of MRP-1/CD9-negative and reduced patients was significantly worse than those of positive patients (n = 108, curative cases, RO). Few cases remained KAI1/CD82-positive (9.6%; 10/104) in oesophageal cancer. Twenty (83.3%) and twenty-two (91.7%) cases out of 24 dysplasias were defined as KAI1/CD82-positive and MRP1/CD9-positive, respectively. The decrease in MRP-1/CD9 and KAI1/CD82 expression may facilitate lymph node metastasis in oesophageal squamous cell carcinomas. Knowing the status of the expression of MRP-1/CD9 appears helpful in predicting the prognosis for each patient. | lld:pubmed |
pubmed-article:10098753 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10098753 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10098753 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10098753 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10098753 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10098753 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10098753 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10098753 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10098753 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10098753 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10098753 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10098753 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10098753 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10098753 | pubmed:language | eng | lld:pubmed |
pubmed-article:10098753 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10098753 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:10098753 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10098753 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10098753 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10098753 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10098753 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10098753 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10098753 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10098753 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10098753 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:10098753 | pubmed:month | Mar | lld:pubmed |
pubmed-article:10098753 | pubmed:issn | 0007-0920 | lld:pubmed |
pubmed-article:10098753 | pubmed:author | pubmed-author:ShimadaYY | lld:pubmed |
pubmed-article:10098753 | pubmed:author | pubmed-author:ImamuraMM | lld:pubmed |
pubmed-article:10098753 | pubmed:author | pubmed-author:UchidaSS | lld:pubmed |
pubmed-article:10098753 | pubmed:author | pubmed-author:MiyakeMM | lld:pubmed |
pubmed-article:10098753 | pubmed:author | pubmed-author:WatanabeGG | lld:pubmed |
pubmed-article:10098753 | pubmed:author | pubmed-author:HoodHH | lld:pubmed |
pubmed-article:10098753 | pubmed:author | pubmed-author:LiZ GZG | lld:pubmed |
pubmed-article:10098753 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:10098753 | pubmed:volume | 79 | lld:pubmed |
pubmed-article:10098753 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:10098753 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:10098753 | pubmed:pagination | 1168-73 | lld:pubmed |
pubmed-article:10098753 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
pubmed-article:10098753 | pubmed:meshHeading | pubmed-meshheading:10098753... | lld:pubmed |
pubmed-article:10098753 | pubmed:meshHeading | pubmed-meshheading:10098753... | lld:pubmed |
pubmed-article:10098753 | pubmed:meshHeading | pubmed-meshheading:10098753... | lld:pubmed |
pubmed-article:10098753 | pubmed:meshHeading | pubmed-meshheading:10098753... | lld:pubmed |
pubmed-article:10098753 | pubmed:meshHeading | pubmed-meshheading:10098753... | lld:pubmed |
pubmed-article:10098753 | pubmed:meshHeading | pubmed-meshheading:10098753... | lld:pubmed |
pubmed-article:10098753 | pubmed:meshHeading | pubmed-meshheading:10098753... | lld:pubmed |
pubmed-article:10098753 | pubmed:meshHeading | pubmed-meshheading:10098753... | lld:pubmed |
pubmed-article:10098753 | pubmed:meshHeading | pubmed-meshheading:10098753... | lld:pubmed |
pubmed-article:10098753 | pubmed:meshHeading | pubmed-meshheading:10098753... | lld:pubmed |
pubmed-article:10098753 | pubmed:meshHeading | pubmed-meshheading:10098753... | lld:pubmed |
pubmed-article:10098753 | pubmed:meshHeading | pubmed-meshheading:10098753... | lld:pubmed |
pubmed-article:10098753 | pubmed:meshHeading | pubmed-meshheading:10098753... | lld:pubmed |
pubmed-article:10098753 | pubmed:meshHeading | pubmed-meshheading:10098753... | lld:pubmed |
pubmed-article:10098753 | pubmed:meshHeading | pubmed-meshheading:10098753... | lld:pubmed |
pubmed-article:10098753 | pubmed:meshHeading | pubmed-meshheading:10098753... | lld:pubmed |
pubmed-article:10098753 | pubmed:meshHeading | pubmed-meshheading:10098753... | lld:pubmed |
pubmed-article:10098753 | pubmed:year | 1999 | lld:pubmed |
pubmed-article:10098753 | pubmed:articleTitle | Motility-related protein (MRP-1/CD9) and KAI1/CD82 expression inversely correlate with lymph node metastasis in oesophageal squamous cell carcinoma. | lld:pubmed |
pubmed-article:10098753 | pubmed:affiliation | Department of Surgery and Surgical Basic Science, Graduate School of Medicine, Kyoto University, Japan. | lld:pubmed |
pubmed-article:10098753 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:10098753 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10098753 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10098753 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10098753 | lld:pubmed |